Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GEBBIA, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.510
EU - Europa 2.036
AS - Asia 893
SA - Sud America 11
AF - Africa 9
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.472
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.489
IT - Italia 679
CN - Cina 389
SG - Singapore 358
UA - Ucraina 310
FI - Finlandia 225
IE - Irlanda 162
GB - Regno Unito 150
DE - Germania 140
RU - Federazione Russa 107
SE - Svezia 95
FR - Francia 57
HK - Hong Kong 46
IN - India 28
PL - Polonia 24
RO - Romania 21
KR - Corea 18
TR - Turchia 18
BE - Belgio 16
NL - Olanda 16
CA - Canada 11
MX - Messico 10
BR - Brasile 8
AT - Austria 7
CI - Costa d'Avorio 7
IR - Iran 7
AU - Australia 6
GR - Grecia 6
JP - Giappone 6
CH - Svizzera 5
ES - Italia 4
IL - Israele 4
EU - Europa 3
KW - Kuwait 3
MY - Malesia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
DK - Danimarca 2
EG - Egitto 2
ID - Indonesia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
AR - Argentina 1
AZ - Azerbaigian 1
CL - Cile 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 9.472
Salva come PNG Salva come JPEG
Città #
Fairfield 1.081
Ashburn 571
Woodbridge 563
Houston 498
Chandler 468
Wilmington 413
Seattle 412
Cambridge 352
Singapore 293
Ann Arbor 282
Jacksonville 169
Dublin 162
Palermo 158
Medford 154
Des Moines 118
Altamura 117
Princeton 97
Lawrence 88
Nanjing 86
Santa Clara 70
San Diego 68
Boardman 52
Dearborn 49
Tulsa 47
Hong Kong 41
Beijing 39
London 36
Shenyang 32
Hebei 29
Ludwigshafen am Rhein 25
Milan 24
Helsinki 23
Nanchang 23
Changsha 22
Saint Petersburg 21
Columbus 19
New York 19
Jinan 17
Redwood City 17
Brussels 16
San Paolo di Civitate 16
Seongnam 16
Chicago 15
Jiaxing 15
San Mateo 15
Kumar 14
Tianjin 14
Falls Church 13
Izmir 13
Berlin 12
Ningbo 12
Polska 11
Rome 11
Dallas 10
Guangzhou 10
Warsaw 10
Kunming 9
Los Angeles 9
Moscow 9
Phoenix 9
Zhengzhou 9
Kilburn 8
Abidjan 7
Bremen 7
Springfield 7
Atlanta 6
Florence 6
Munich 6
Orange 6
Rho 6
Venice 6
Verona 6
Washington 6
Frankfurt am Main 5
Kochi 5
Monreale 5
Sandston 5
Tappahannock 5
Frankfurt 4
Hangzhou 4
Mérida 4
Naples 4
Norwalk 4
Paris 4
Taiyuan 4
Taizhou 4
Ankara 3
Bologna 3
Changchun 3
Den Haag 3
Detroit 3
Edinburgh 3
Forest City 3
Fuzhou 3
Haikou 3
Islington 3
Kowloon 3
Kuwait 3
Melfi 3
Piscataway 3
Totale 7.199
Salva come PNG Salva come JPEG
Nome #
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study 309
Does pain intensity predict a poor opioid response in cancer patients? 209
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 189
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 188
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 174
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit. 156
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents 154
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 148
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. 147
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. 144
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study 139
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. 135
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study. 134
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule 134
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 133
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience 132
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor 132
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study 130
Oral versus intravenous vinorelbine: clinical safety profile 129
ELF regimen in advanced gastrointestinal malignancies: An analysis of its clinical effectiveness and toxicity 129
Anticancer oral therapy: Emerging related issues 128
Treatment of metastatic breast cancer with vinorelbine and docetaxel 128
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 125
Oral vinorelbine may not induce acute pain at the tumor site. 124
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials 124
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study 124
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 124
Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin? 122
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases 122
Cetuximab in squamous cell head and neck carcinomas. 119
Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer 119
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). 119
Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials 119
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. 118
Breakthrough pain in oncology: a longitudinal study. 117
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 113
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. 112
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma 112
Combination chemotherapy of 5-Fluorouracil, Epidoxorubicin and Mitomicin C in the palliative treatment of locally-advanced and/or metastatic adenocarcinoma of the stomach. 111
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia. 110
Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer. 108
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer 105
Cetuximab: clinical results in colorectal cancer. 104
Gastric metastasis from breast cancer 104
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 104
Italian clinical research in non-small-cell lung cancer 104
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas 103
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer 102
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 102
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM) 101
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). 100
Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial 100
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel 99
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial 93
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 93
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 92
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. 91
Opioid plasma concentration during switching from morphine to methadone: Preliminary data 85
“Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium” 84
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with gluthatione protection in patients with advanced head and neck cancer 81
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 80
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 79
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.) 78
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 78
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 76
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma 75
Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma 74
MISURARE LA FRAGILITÀ DEL PAZIENTE ONCOLOGICO ANZIANO 72
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale 70
A phase i-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma 70
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 70
Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns 69
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 66
GEMCITABINE AND CISPLATIN FOR INOPERABLE AND/OR METASTATIC BILIARY TREE CARCINOMAS: A MULTICENTER PHASE II STUDY OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE (GOIM) 65
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. 64
Short term intensive preoperative chemotherapy with high doses of epirubicin plus G-CSF rescue for locally advanced Stage III breast carcinoma. 64
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 64
Vinorelbine plus cisplatinum for the treatment of Stage IIIB and IV Non Small Cell Lung Carcinoma. 63
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World 63
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 61
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 61
Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study 60
Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM) 58
Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management. 56
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? 52
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 52
Chemotherapy for endometrial carcinoma 51
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 51
Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma 50
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 50
Mitoxantrone + Prednisone versus Taxotere + Prednisone nel trattamento del carcinoma prostatico ormonorefrattario (cpor ). Studio randomizzato di fase II del Gruppo Oncologico dell’Italia Meridionale (GOIM ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 47
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken 45
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial 44
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 43
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer 36
Cancer: New needs, new models. is it time for a community oncologist? another brick in the wall 36
Latissimus Dorsi Flap and Thoracodorsal Artery Perforator Flap with Immediate Fat Transfer (LIFT and TIFT): A Retrospective Study about Total Breast Reconstruction in High-Risk Patients 33
Management of Patients with Gastric or Gastroesophageal Junction Cancer: From Theory to Integrated Clinical Path- ways Implementation in the Real World 30
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study 27
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 27
Totale 9.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.366 0 0 0 0 0 296 270 174 253 123 159 91
2020/20211.745 109 113 281 129 197 81 129 94 130 175 147 160
2021/20221.196 79 260 13 62 58 42 69 57 145 149 62 200
2022/20231.411 134 321 27 126 162 232 91 80 136 12 46 44
2023/2024602 29 97 67 48 37 92 46 27 12 15 40 92
2024/2025689 50 166 183 144 96 50 0 0 0 0 0 0
Totale 9.947